Benralizumab's anti-eosinophil efficacy may be decreased by impaired NK cell activity
Sophie M. Poznanski, Ana Portillo, Manali Mukherjee, Anurag Bhalla, Kiho Son, Ali A. Ashkar, Nader Khalidi, Parameswaran Nair
Source: Eur Respir J, 59 (4) 2102210; 10.1183/13993003.02210-2021
  
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sophie M. Poznanski, Ana Portillo, Manali Mukherjee, Anurag Bhalla, Kiho Son, Ali A. Ashkar, Nader Khalidi, Parameswaran Nair. Benralizumab's anti-eosinophil efficacy may be decreased by impaired NK cell activity. Eur Respir J, 59 (4) 2102210; 10.1183/13993003.02210-2021
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|